Journal
JOURNAL OF KOREAN MEDICAL SCIENCE
Volume 19, Issue 2, Pages 209-213Publisher
KOREAN ACAD MEDICAL SCIENCES
DOI: 10.3346/jkms.2004.19.2.209
Keywords
methylenetetrahydrofolate reductase (NADPH2); uric acid; hyperuricemia; cardiovascular diseases; risk factors
Categories
Ask authors/readers for more resources
The C677T mutation in the methylene tetrahydrofolate reductase (MTHFR) gene results in elevated homocysteine levels and, presumably, in increased cardiovascular risk. Moreover, elevated homocysteine levels are reportedly associated with high serum uric acid levels. We evaluated the MTHFR genotype and a panel of biochemical, hematological variables, and lifestyle characteristics in 327 elderly Korean men (age range 40-81 yr; mean, 51.87). This study shows that mutation of the MTHFR gene may be a risk for hyperuricemia. The mean uric acid levels for the C/C, C/T and T/T genotypes were 5.54, 5.91 and 6.33 mg/dL, respectively (p = 0.000), The T/T genotype was significantly more frequent in subjects with high uric acid levels (p = 0.003). Thus, this mutation of the MTHFR gene is implied by the study results to be a risk factor of hyperuricemia in elderly Korean men. However, the relationship between the MTHFR mutation and uric acid metabolism remains unclear. Therefore, further studies are necessary to explain the associated between the MTHFR mutation and elevated uric acid levels, and to examine potential relationships between it and conventional cardiovascular risk factors.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available